Celebrity chef Gordon Ramsay has once again stirred controversy, unleashing a famously profane verbal attack against individuals using weight-loss medications, such as Ozempic and Mounjaro, and strongly rejecting the idea of adapting his restaurant menus to accommodate them.

Ramsay, 63 (based on his age mentioned in a recent interview, which conflicts slightly with the original article's publication date), whose penchant for not mincing words has frequently landed him in hot water, gave an uncompromising interview to The Sunday Times where he addressed the growing trend of high-end eateries adjusting their offerings for diners with reduced appetites (People).

Ramsay’s Expletive-Filled Refusal

When directly questioned about whether his global portfolio of restaurants would follow other chefs in creating reduced-portion or "mindful" menus, Ramsay's response was explosive.

“That is absolute [expletive],” Ramsay fumed. “There’s no [expletive]ing way we’re giving in to the jab… The problem is with them [the diners] for eating too much in the first [expletive]ing place!” (The Sunday Times via People).

He further rejected the concept of tailoring the fine-dining experience to fit the new demographic. "There's no way that we're coming in with an Ozempic tasting menu to make you feel like less of a fat [expletive] by 10:30 in the evening,” he declared, firmly stating that his establishments will not be changing for any dietary trends related to these drugs (Parade).

Ramsay concluded that individuals should focus on self-discipline and achieving balance, a philosophy he attributes to his own longevity in the demanding culinary industry (The Times).

---

The Industry Divide: Catering to the 'Appetite Recession'

Ramsay’s staunch refusal puts him directly at odds with other notable figures in the hospitality sector who are actively addressing the "Appetite Recession" caused by the surge in GLP-1 medications.

• Heston Blumenthal's 'Mindful Experience': Chef Heston Blumenthal—who himself uses a weight-loss drug (Mounjaro) to manage weight gain caused by bipolar medication—launched a "Mindful Experience" reduced-portion tasting menu at his three-Michelin-starred restaurant, The Fat Duck in Bray, Berkshire, in September (The Caterer). The new menu is priced at £275 per person, compared to the standard "Journey" menu at £350 (The Caterer). Blumenthal noted that millions of people are "eating much less food, drinking less, losing interest in restaurants, losing interest even in food itself," and his menu is designed to allow users to savour the complex culinary experience in a size that suits their new appetites (Fruitnet).

• Other Adaptations: Similarly, chef Antony Worrall Thompson announced he was exploring more sharing menus at his Kew restaurant, Grill Off The Green, to accommodate guests' reduced capacity (Entertainment Daily). In New York, the Italian restaurant Tucci introduced a specific "Ozempic Menu" featuring daintier, smaller-plate versions of popular dishes, while the burger chain Clinton Hall launched "The Teeny-Weeny Mini Meal" for customers with reduced appetites (Globetrender).

According to research compiled by Morgan Stanley, 63% of individuals taking Ozempic-like drugs report ordering "considerably less" when dining out than they did previously (Globetrender). This significant shift in consumer behavior is forcing restaurants, particularly those with fixed-price tasting menus, to re-evaluate their entire business model (Newsweek). An August 2025 study by the non-profit RAND projected that 10-12% of Americans now use GLP-1 medications, forecasting a potential 3% decrease in total food intake across North America by 2030 (Globetrender).

Ramsay's comments highlight the philosophical clash occurring within the industry: the traditional value of abundance and indulgence versus the new reality of mindful, controlled consumption.

A Focus on Discipline

Ramsay's emphasis on personal discipline is consistent with his own public health journey. The chef, who recently shared an update following a skin cancer scare, has long been a proponent of fitness, famously competing in Ironman triathlons (People). His current comments reinforce his long-held belief that dietary control should stem from internal motivation rather than a pharmacological shortcut.